DRESS syndrome, a drug reaction which remains bad known from paediatricians;Le DRESS syndrome, une réaction d'hypersensibilité aux médicaments, qui reste mal connue des pédiatres

Archives de Pediatrie

Volumn 14, Issue 12, 2007, Pages 1439-1441

  Autret Leca, E ^a,b   Norbert, K ^c   Bensouda Grimaldi, L ^a,b   Jonville Bera A P ^a   Saliba, E ^c   Bentata, J ^d   Barthez Carpentier, M A ^c  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Centre de Pediatrie Clocheville   (France)

^d CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; METHYLPREDNISOLONE SODIUM SUCCINATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE 3 SULFOBENZOATE; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HEPATITIS; HUMAN; LEUKOCYTOSIS; PLEURISY; RASH; RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS; RECURRENT DISEASE; DIFFERENTIAL DIAGNOSIS; SYNDROME;

ANTICONVULSANTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; SYNDROME;

EID: 36448954725     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2007.07.016     Document Type: Article

References (20)

1. Bocquet H., Bagot M., and Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin. Cutan. Med. Surg. 15 (1996) 250-257
2. Howard P.A., Engen P.L., and Dunn M.I. Phenytoin hypersensitivity syndrome: a case report. DICP 25 (1991) 929-932
3. Bessmertny O., Hatton R.C., and Gonzalez-Peralta R.P. Antiepileptic hypersensitivity syndrome in children. Ann. Pharmacother. 35 (2001) 533-538
4. Bosdure E., Cano A., Roquelaure B., et al. Oxcarbazépine et syndrome DRESS : un cas pédiatrique révélé par une hépatite fulminante. Arch. Pediatr. 11 (2004) 1073-1077
5. Carroll M.C., Yueng-Yue K.A., Esterly N.B., et al. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 108 (2001) 485-492
6. Beran R.G. Cross-reactive skin eruption with both carbamazepine and oxcarbazepine. Epilepsia 34 (1993) 163-165
7. Vittorio C.C., and Muglia J.J. Anticonvulsant hypersensitivity syndrome. Arch. Intern. Med. 155 (1995) 2285-2290
8. Pradalier A., Teillet F., Molitor J.L., et al. Syndrome d'activation macrophagique (syndrome d'hémophagocytose). Pathol. Biol. 52 (2004) 407-414
9. Arevalo-Lorido J.C., Carretero-Gomez J., Bureo-Dacal J.C., et al. Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate. Br. J. Clin. Pharmacol. 55 (2003) 415-416
10. Bavdekar S.B., Muranjan M.N., Gogtay N.J., et al. Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann. Pharmacother. 38 (2004) 1648-1650
11. Mylonakis E., Vittorio C.C., Hollik D.A., et al. Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome. Ann. Pharmacother. 33 (1999) 557-559
12. Veyrac G., Marcade G., Chiffoleau A., et al. Caractéristiques du syndrome d'hypersensibilité à la lamotrigine : revue à partir d'un cas observé au CRPV de Nantes. Therapie 57 (2002) 289-296
13. Knowles S.R., Shapiro L.E., and Shear N.H. Anticonvulsant hypersensitivity syndrome : incidence, prevention and management. Drug Saf. 21 (1999) 489-501
14. Veyrac G., Marcade G., Chiffoleau A., et al. Caractéristiques du syndrome d'hypersensibilité à la lamotrigine : revue à partir d'un cas observé au CRPV de Nantes. Therapie 57 (2002) 289-296
15. Descamps V., Valance A., Edlinger C., et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 137 (2001) 301-304
16. Aihara M., Sugita Y., Takahashi S., et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br. J. Dermatol. 144 (2001) 1231-1234
17. Leeder J.S., Riley R.J., Cook V.A., et al. Human anticytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J. Pharmacol. Exp. Ther. 263 (1992) 360-367
18. Sullivan J.R., and Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch. Dermatol. 137 (2001) 357-364
19. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol. Online J. 8 (2002) 5
20. Morand J.J., Lightburn E., Coton T., et al. Syndrome d'hypersensibilité médicamenteuse rapidement résolutif après perfusion d'immunoglobulines humaines. Ann. Dermatol. Venereol. 128 (2001) 1351-1353